about
Control of prostate cell growth: BMP antagonizes androgen mitogenic activity with incorporation of MAPK signals in Smad1Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistanceActivation of the RalGEF/Ral pathway promotes prostate cancer metastasis to boneSaposin C promotes survival and prevents apoptosis via PI3K/Akt-dependent pathway in prostate cancer cellsAcquisition of androgen independence by human prostate epithelial cells during arsenic-induced malignant transformation.Chemotherapy and its evolving role in the management of advanced prostate cancerInorganic arsenic and human prostate cancerRREB1 transcription factor splice variants in urologic cancer.Cystatin C is downregulated in prostate cancer and modulates invasion of prostate cancer cells via MAPK/Erk and androgen receptor pathways.NPM1 silencing reduces tumour growth and MAPK signalling in prostate cancer cells.TPL2/COT/MAP3K8 (TPL2) activation promotes androgen depletion-independent (ADI) prostate cancer growth.Polyisoprenylated methylated protein methyl esterase as a putative drug target for androgen-insensitive prostate cancer.GPRC6A regulates prostate cancer progressionRasGRP3 contributes to formation and maintenance of the prostate cancer phenotype.Phase II study of androgen synthesis inhibition with ketoconazole, hydrocortisone, and dutasteride in asymptomatic castration-resistant prostate cancer.Androgen receptor phosphorylation and stabilization in prostate cancer by cyclin-dependent kinase 1.Rationally designed treatment for solid tumors with MAPK pathway activation: a phase I study of paclitaxel and bortezomib using an adaptive dose-finding approach.Oncogenic ETS proteins mimic activated RAS/MAPK signaling in prostate cells.Mechanisms mediating androgen receptor reactivation after castration.Mechanisms of acquired androgen independence during arsenic-induced malignant transformation of human prostate epithelial cells.Antagonists of growth hormone-releasing hormone inhibit growth of androgen-independent prostate cancer through inactivation of ERK and Akt kinasesSelective amino acid restriction differentially affects the motility and directionality of DU145 and PC3 prostate cancer cells.The androgen receptor and signal-transduction pathways in hormone-refractory prostate cancer. Part 2: Androgen-receptor cofactors and bypass pathways.Structure-based virtual screening and identification of a novel androgen receptor antagonist.Novel oncogene-induced metastatic prostate cancer cell lines define human prostate cancer progression signatures.Alteration of Akt activity increases chemotherapeutic drug and hormonal resistance in breast cancer yet confers an achilles heel by sensitization to targeted therapy.Ras signaling influences permissiveness of malignant peripheral nerve sheath tumor cells to oncolytic herpesXenobiotic metabolizing gene variants, dietary heterocyclic amine intake, and risk of prostate cancerETV4 promotes metastasis in response to activation of PI3-kinase and Ras signaling in a mouse model of advanced prostate cancer.The genetics of castration-resistant prostate cancer: what can the germline tell us?Role of HMG-CoA reductase inhibitors with curative radiotherapy in men with prostate cancer.ARF1 promotes prostate tumorigenesis via targeting oncogenic MAPK signaling.Polycomb group protein enhancer of zeste 2 is an oncogene that promotes the neoplastic transformation of a benign prostatic epithelial cell lineIntegrin signaling aberrations in prostate cancer.Aberrant microRNA expression likely controls RAS oncogene activation during malignant transformation of human prostate epithelial and stem cells by arsenic.New agents and strategies for the hormonal treatment of castration-resistant prostate cancer.Androgen action and metabolism in prostate cancer.Abiraterone acetate for the treatment of prostate cancer.Silencing KRAS Overexpression in Cadmium-Transformed Prostate Epithelial Cells Mitigates Malignant PhenotypeThe current evidence on statin use and prostate cancer prevention: are we there yet?
P2860
Q24337748-743B9CE4-2029-4B6C-A501-7775048ADB6EQ24645668-11FB6FC0-5FA5-4B34-9E9B-E8C5D129644DQ24681479-F3EAF03F-8C46-4C39-A9AE-338F57C13070Q24801685-EF9FAB0C-D333-4319-AD72-D905AD0DFD70Q24815477-E565F283-2442-45AF-98D5-6B77E340258BQ27008883-1A329F0C-012F-43E0-8590-DE1D760E2762Q28383469-F4091320-6479-4B03-AAAA-E48CA58983E0Q30426139-186A8694-10B4-43F4-B29C-7524057E916BQ33517129-9813152A-8CC9-428C-864C-AF30A1BAD7A6Q33567915-14701DB7-04CA-4058-9385-AA1A32E4C04DQ33803841-67318ED9-DA2C-4C3C-A5BF-90941328881AQ34135178-7CA0DFFF-435A-4DDF-97C1-E9A69FFDC417Q34193432-26294DD3-FA5F-43E2-9D26-92C93C5DCF15Q34203989-876E3B28-1D30-4A56-AE2B-A21AD38FCE6BQ35011129-1788BE9B-E24E-4598-A019-F429F4B0609CQ35127580-675B9D60-2BAC-4C0B-8872-20E2F7E18771Q35161796-D5CDE22B-DC9B-4BC1-A711-195CBC846CE1Q35493982-1D20FC2D-1331-461B-A599-1940E07441AFQ35633454-592DB98B-A3CC-44DC-999C-777A444AE252Q35672221-F0D3A802-2DE9-42C5-89D4-A8D332B47271Q35749794-F5B84180-5A47-48C6-A68E-352726F92816Q36106835-DB5CF46D-D1E2-4311-83F7-6F609DC843C3Q36126920-A63B864D-9FB0-4D9B-A67B-7631F0A07A6EQ36216496-D4F281C4-A310-42E8-9577-C199AEF98EEBQ36580194-AC4F91BD-F8C5-49FE-93AA-F988F0B8054BQ36973814-E81E41C7-6A04-4BA7-9AD1-C9CB273102FBQ37061120-097ED59E-AAF3-47AD-9880-F9CF209E494FQ37143504-053A21A9-44F6-4158-9377-923C095DA7BAQ37173209-127BBDEC-1665-43B8-8FCC-E23D31CDE6D1Q37233298-9E35CA3C-11B2-49A6-A09F-4CE6774D9FABQ37283766-9B02B200-087E-49A8-BF91-F992D418ED82Q37457689-E7C4B03A-B3E7-4B50-9970-09AAA18D49B9Q37478998-57324220-276A-4DD5-995E-1A3DE822D59DQ37643449-BC70BA08-428E-47A1-895D-CFD6FAAE3A84Q37669900-840DDF85-D435-425E-BE40-B2E07261E154Q37762808-EE583DAD-F958-4344-B809-BF0301CCA396Q37997571-17F0D334-D23F-43A6-9869-56059628C6E5Q38063964-FF075AAC-9764-4CFF-9677-AAA411680DBEQ38752633-9FC2E7F4-9C63-4FF6-A806-DCC79F564EE4Q38800777-CCBF7E9F-B6AA-4955-82DA-C3C892CFB1CE
P2860
description
2004 nî lūn-bûn
@nan
2004 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Ras signaling in prostate cancer progression.
@ast
Ras signaling in prostate cancer progression.
@en
type
label
Ras signaling in prostate cancer progression.
@ast
Ras signaling in prostate cancer progression.
@en
prefLabel
Ras signaling in prostate cancer progression.
@ast
Ras signaling in prostate cancer progression.
@en
P2860
P356
P1476
Ras signaling in prostate cancer progression.
@en
P2093
Daniel Gioeli
Michael J Weber
P2860
P356
10.1002/JCB.10683
P577
2004-01-01T00:00:00Z